Renal - Acute
Payments companies reported to CMS as associated with Renal - Acute. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Renal - Acute, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Renal - Acute
These are the largest totals companies reported as associated with Renal - Acute. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ram Subramanian | Atlanta, GA | Hepatology | $167,256.05 |
| Javier Neyra Lozano | Lexington, KY | Nephrology (Internal Medicine) | $76,562.59 |
| Francisco Flores | Cincinnati, OH | Pediatric Nephrology | $63,744.64 |
| Stuart Goldstein | Cincinnati, OH | Pediatric Nephrology | $63,229.22 |
| Barbara Mclean | Atlanta, GA | $60,505.37 | |
| Rajit Basu | Atlanta, GA | Pediatric Critical Care Medicine | $51,150.39 |
| Jay Koyner | Chicago, IL | Nephrology (Internal Medicine) | $34,580.80 |
| Lenar Yessayan | Ann Arbor, MI | Nephrology (Internal Medicine) | $33,185.23 |
| Anjali Saxena | San Jose, CA | Nephrology (Internal Medicine) | $32,379.74 |
| Luis Juncos | Little Rock, AR | Nephrology (Internal Medicine) | $27,046.79 |
Prescribed Renal - Acute?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.